HIV infection, symptomatic
071.1
Infectious Diseases
Both
050-079.99
ICD mappings
| ICD code | Type | Description | Phenome |
|---|---|---|---|
| B20 | ICD10CM | Human immunodeficiency virus [HIV] disease | MGI |
| 042 | ICD9CM | Human immunodeficiency virus [HIV] disease | MGI |
| B20.0 | ICD10 | B20.0 HIV disease resulting in mycobacterial infection | UKB |
| B20.1 | ICD10 | B20.1 HIV disease resulting in other bacterial infections | UKB |
| B20.2 | ICD10 | B20.2 HIV disease resulting in cytomegaloviral disease | UKB |
| B20.3 | ICD10 | B20.3 HIV disease resulting in other viral infections | UKB |
| B20.4 | ICD10 | B20.4 HIV disease resulting in candidiasis | UKB |
| B20.6 | ICD10 | B20.6 HIV disease resulting in Pneumocystis carinii pneumonia | UKB |
| B20.8 | ICD10 | B20.8 HIV disease resulting in other infectious and parasitic diseases | UKB |
| B21.1 | ICD10 | B21.1 HIV disease resulting in Burkitt's lymphoma | UKB |
| B21.2 | ICD10 | B21.2 HIV disease resulting in other types of non-Hodgkin's lymphoma | UKB |
| B21.3 | ICD10 | B21.3 HIV disease resulting in other malignant neoplasms of lymphoid, haematopoietic and related tissue | UKB |
| B21.8 | ICD10 | B21.8 HIV disease resulting in other malignant neoplasms | UKB |
| B22.0 | ICD10 | B22.0 HIV disease resulting in encephalopathy | UKB |
| B22.2 | ICD10 | B22.2 HIV disease resulting in wasting syndrome | UKB |
| B22.7 | ICD10 | B22.7 HIV disease resulting in multiple diseases classified elsewhere | UKB |
| B23.0 | ICD10 | B23.0 Acute HIV infection syndrome | UKB |
| B23.2 | ICD10 | B23.2 HIV disease resulting in haematological and immunological abnormalities, not elsewhere classified | UKB |
| B23.8 | ICD10 | B23.8 HIV disease resulting in other specified conditions | UKB |
| B24 | ICD10 | B24 Unspecified human immunodeficiency virus [HIV] disease | UKB |
This page is mainly a phenotype dictionary entry. When you are trying to find candidate PRS models, go to the Scores table, search by trait or exposure name, and then use the score-detail and PheWAS pages for model-specific follow-up.